First Time Loading...

Burning Rock Biotech Ltd
NASDAQ:BNR

Watchlist Manager
Burning Rock Biotech Ltd Logo
Burning Rock Biotech Ltd
NASDAQ:BNR
Watchlist
Price: 0.7 USD Market Closed
Updated: Mar 28, 2024

Burning Rock Biotech Ltd
Revenue

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

Burning Rock Biotech Ltd
Revenue Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Burning Rock Biotech Ltd
NASDAQ:BNR
Revenue
¥563.2m
CAGR 3-Years
14%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Revenue
¥9.6B
CAGR 3-Years
48%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Revenue
¥4.6B
CAGR 3-Years
63%
CAGR 5-Years
201%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Revenue
¥11.2B
CAGR 3-Years
111%
CAGR 5-Years
64%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Revenue
¥49.7B
CAGR 3-Years
53%
CAGR 5-Years
65%
CAGR 10-Years
50%
Imeik Technology Development Co Ltd
SZSE:300896
Revenue
¥1.9B
CAGR 3-Years
51%
CAGR 5-Years
54%
CAGR 10-Years
N/A

Burning Rock Biotech Ltd
Revenue Breakdown

Breakdown by Geography
Burning Rock Biotech Ltd

Total Revenue: 563.2m CNY
100%
China: 553.3m CNY
98.2%

Breakdown by Segments
Burning Rock Biotech Ltd

Total Revenue: 563.2m CNY
100%
Central Laboratory Business: 314.8m CNY
55.9%
Inhospital Business: 175.3m CNY
31.1%
Pharma Research And Development Services: 73.2m CNY
13%

See Also

What is Burning Rock Biotech Ltd's Revenue?
Revenue
563.2m CNY

Based on the financial report for Dec 31, 2022, Burning Rock Biotech Ltd's Revenue amounts to 563.2m CNY.

What is Burning Rock Biotech Ltd's Revenue growth rate?
Revenue CAGR 5Y
38%

Over the last year, the Revenue growth was 11%. The average annual Revenue growth rates for Burning Rock Biotech Ltd have been 14% over the past three years , 38% over the past five years .